10-07 Abbott introduces Ensure® Max Protein 3-in-1 Muscle Support, bringing the benefits of a supplement stack into one scoop PR
10-07 Abbott Introduces Ensure Max Protein 3-In-1 Muscle Support Protein Powder CI
10-07 Barclays Initiates Coverage on Abbott Laboratories With Overweight Rating, $120 Price Target MT
10-05 Abbott Laboratories Receives FDA Approval for New CardioMEMS HF System capabilities CI
10-05 Abbott Laboratories Receives FDA Approval to Include Interactive Features in CardioMEMS Heart Monitor MT
10-05 Abbott receives FDA approval for new CardioMEMS HF System capabilities that help patients engage in the care of their heart condition PR
10-05 Evercore ISI Adjusts Price Target on Abbott Laboratories to $124 From $120, Keeps Outperform Rating MT
10-02 Rothschild & Co Redburn Upgrades Abbott Laboratories to Buy From Neutral, Adjusts PT to $127 From $119 MT
10-02 Rothschild & Co Redburn Upgrades Abbott Laboratories to Buy From Neutral, Adjusts PT to $127 From $119 MT
09-30 Abbott Launches Simplescreen Crc Blood Test in the U.S CI
09-30 Abbott Launches SimpleScreen Blood Test for Colorectal Cancer MT
09-30 Abbott hosts conference call for third-quarter earnings PR
09-30 Abbott launches SimpleScreen™ CRC blood test, joining Cologuard Plus® in its colorectal cancer screening portfolio PR
09-24 Abbott Laboratories : Landmark study in people with Type 2 diabetes using basal insulin shows continuous glucose monitoring, including Abbott’s Libre technology, associated with lower risk of death and cardiovascular complications PU
09-23 Abbott and Berry Street team up on personalized nutrition tracking Zonebourse
09-23 Abbott and Berry Street Partner To Expand Personalized Nutrition Support For Consumers Seeking Better Metabolic Health CI
09-23 Abbott And Berry Street Partner To Expand Personalized Nutrition Support For Consumers Seeking Better Metabolic Health PR
09-18 Trinity Heart Experts First in the Quad Cities to Use New Afib Technology CI
09-17 Abbott Laboratories Declares Quarterly Dividend, Payable on Nov. 16, 2026 CI
09-17 Abbott Laboratories Keeps Quarterly Dividend at $0.63 a Share, Payable Nov. 16 to Holders of Record on Oct. 15 MT
09-17 Abbott declares 411th consecutive quarterly dividend PR
09-15 Abbott Announces First Canadian Use of Volt Pulsed Field Ablation System to Treat Atrial Fibrillation CI
09-15 First Canadian Commercial Use of Abbott's Volt™ Pulsed Field Ablation System Advances Minimally Invasive Atrial Fibrillation Care AQ
09-15 Abbott to pay $385M over infant formula contamination probe AQ
09-14 Abbott agrees to settlement over closure of largest baby formula plant in the US AQ
No results match your criteria
  1. Stock Market
  2. Stocks
  3. ABT Stock
  4. News Abbott Laboratories